William Blum
Emory University · Ohio State University Comprehensive Cancer Center · Ohio State University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name William Blum as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:58 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04872478 · Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALMeryx, Inc. · recruiting · Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia · principal investigator
- Ph2NCT02730195 · Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid LeukemiaEmory University · terminated · Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive · principal investigator
- Ph2NCT02709083 · Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid LeukemiaEmory University · terminated · Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Leukemia · principal investigator
- Ph1NCT01132586 · Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI) · completed · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 · principal investigator
- Ph1NCT00703300 · Decitabine and Bortezomib in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI) · completed · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) · principal investigator
- Ph2NCT00492401 · Decitabine in Treating Patients With Previously Untreated Acute Myeloid LeukemiaNational Cancer Institute (NCI) · completed · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) · principal investigator
- Ph2NCT00416598 · Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid LeukemiaNational Cancer Institute (NCI) · completed · Acute Myeloid Leukemia, Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 · principal investigator
- Ph1NCT00101231 · Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaNational Cancer Institute (NCI) · terminated · Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Experimental Therapeutics in Acute LeukemiasK23CA120708 · NCI · OHIO STATE UNIVERSITY · fiscal years 2006 to 2010 · $129,720 awarded in 2010Same name and institution; not confirmed by an ID
- Maintenance therapy with decitabine for acute myeloid leukemia in first remissionR21CA128377 · NCI · OHIO STATE UNIVERSITY · fiscal years 2009 to 2010 · $330,000 awarded in 2010Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- U01CA076576RePORTER returned no project for this number; it is shown as the registry gives it.
- The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials NetworkUM1CA186712 · NCI · OHIO STATE UNIVERSITY · PI SUSANNE M ARNOLD, WILLIAM E. CARSON, Narendranath Epperla · fiscal years 2017 to 2026Named on NCT01132586
- Shared Resource 10: Pharmacoanalytical Shared Resource (PhASR)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Mitch A Phelps · fiscal years 2016 to 2026Named on NCT01132586, NCT00703300
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2017 to 2026Named on NCT00416598
- U10CA031946RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00416598
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.